ReviewCardiovascular diabetology2019

New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.

Upendra Kaul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.